Edition:
United Kingdom

Intellipharmaceutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

0.76USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
47,236
52-wk High
$3.11
52-wk Low
$0.75

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.02 November 13 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Nov-17 3 3.94 5.29 1.52 17.73
Quarter Ending Feb-18 1 8.67 8.67 8.67 26.77
Year Ending Nov-17 3 9.82 11.74 6.14 20.21
Year Ending Nov-18 3 24.72 34.30 7.56 84.11
Earnings (per share)
Quarter Ending Nov-17 3 -0.02 0.03 -0.08 0.40
Quarter Ending Feb-18 1 0.11 0.11 0.11 0.57
Year Ending Nov-17 3 -0.20 -0.11 -0.29 0.09
Year Ending Nov-18 3 0.22 0.51 -0.28 1.70

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Aug-17 2.64 1.19 1.46 55.02
Quarter Ending May-17 1.84 2.00 0.16 8.91
Quarter Ending Feb-17 1.84 1.24 0.60 32.70
Quarter Ending Nov-16 1.32 0.57 0.75 56.79
Quarter Ending Aug-16 0.53 0.55 0.03 5.23

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Nov-17 3.94 3.94 3.94 3.94 17.73
Quarter Ending Feb-18 8.67 8.67 8.67 8.67 26.77
Year Ending Nov-17 9.82 9.82 9.82 9.82 20.21
Year Ending Nov-18 24.72 24.72 24.72 24.72 84.11

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Nov-17 0 0 0 0
Quarter Ending Feb-18 0 0 0 0
Year Ending Nov-17 0 0 0 0
Year Ending Nov-18 0 0 0 0
Earnings